EE350 Cost-Effectiveness Analysis of Xigduo (EXTENDED-RELEASE DAPAGLIFLOZIN-METFORMIN TABLETS) for Managing Type 2 Diabetes Mellitus (T2DM) Patients
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.648
https://www.valueinhealthjournal.com/article/S1098-3015(24)00763-0/fulltext
Title :
EE350 Cost-Effectiveness Analysis of Xigduo (EXTENDED-RELEASE DAPAGLIFLOZIN-METFORMIN TABLETS) for Managing Type 2 Diabetes Mellitus (T2DM) Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00763-0&doi=10.1016/j.jval.2024.03.648
First page :
Section Title :
Open access? :
No
Section Order :
10124